Investors

Building a Biopharmaceutical Company

Investors

Lexicon Pharmaceuticals is a biopharmaceutical company focused on developing breakthrough treatments for human disease.

Stock Quote Events & Webcasts
NASDAQ: LXRX
7.68
+0.54 (+7.56%)
Range 7.17 - 7.70
Open 7.18
Prev Close 7.14
52 Week 5.60 - 12.74
Volume 492882
Market Cap 5.57B
*Delayed 5/22/2015 4:00 EDT

 

Investor and Media Relations Contact
Corporate Communications and Investor Relations
Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands, TX 77381-1160
281.863.3000